Lymphoma, Pathology, Internal medicine, MALT lymphoma and Helicobacter pylori are his primary areas of study. His studies in Lymphoma integrate themes in fields like Marginal zone and Gastric mucosa. His Pathology research incorporates elements of Gene rearrangement and B cell.
His Internal medicine study combines topics from a wide range of disciplines, such as Gastroenterology, Surgery and Oncology. His research in Gastroenterology intersects with topics in Oxaliplatin and Capecitabine. His Lymphatic system research is multidisciplinary, incorporating elements of Stomach and Antibody.
Andrew Wotherspoon spends much of his time researching Pathology, Internal medicine, Lymphoma, Oncology and Colorectal cancer. His Pathology research includes themes of Gene rearrangement, Immunophenotyping and B cell. The concepts of his Internal medicine study are interwoven with issues in Gastroenterology and Surgery.
He has included themes like Helicobacter pylori and Lymphatic system in his Lymphoma study. He has researched Lymphatic system in several fields, including Stomach and Gastric mucosa. In Oncology, Andrew Wotherspoon works on issues like Epirubicin, which are connected to Panitumumab.
Andrew Wotherspoon mainly focuses on Internal medicine, Oncology, Cancer, Cancer research and Pathology. His Oncology research incorporates themes from Chemotherapy, High grade B-cell lymphoma, Meta-analysis, Retrospective review and Adenocarcinoma. His biological study spans a wide range of topics, including Clinical trial and Progression-free survival.
His Cancer research research includes elements of Colorectal cancer, Single-nucleotide polymorphism, Gene and Immune system. His research on Pathology frequently connects to adjacent areas such as Relapsed Angioimmunoblastic T-cell Lymphoma. His work deals with themes such as Peripheral and Amyloidosis, which intersect with Lymphoma.
His primary areas of study are Internal medicine, Oncology, Colorectal cancer, Cancer research and Cetuximab. Much of his study explores Internal medicine relationship to Gastroenterology. His Oncology study also includes fields such as
His Colorectal cancer research is multidisciplinary, incorporating perspectives in Proportional hazards model, Primary tumor, Tumor Regression Grade and Digital polymerase chain reaction. Andrew Wotherspoon interconnects Immune checkpoint, ALK-Positive, Lorlatinib and Transformation in the investigation of issues within Cancer research. The various areas that Andrew Wotherspoon examines in his Cetuximab study include Biomarker, KRAS, Immune system and Gene mutation.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori
A.C. Wotherspoon;T.C. Diss;L. Pan;P.G. Isaacson.
The Lancet (1993)
Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma
A.C. Wotherspoon;C. Ortiz-Hidalgo;M.R. Falzon;P.G. Isaacson.
The Lancet (1991)
Epirubicin, oxaliplatin, and capecitabine with or without panitumumab for patients with previously untreated advanced oesophagogastric cancer (REAL3): a randomised, open-label phase 3 trial
Tom Waddell;Ian Chau;David Cunningham;David Gonzalez.
Lancet Oncology (2013)
Neoadjuvant Capecitabine and Oxaliplatin Followed by Synchronous Chemoradiation and Total Mesorectal Excision in Magnetic Resonance Imaging–Defined Poor-Risk Rectal Cancer
Ian Chau;Gina Brown;David Cunningham;Diana Tait.
Journal of Clinical Oncology (2006)
Multicenter Randomized Phase II Clinical Trial Comparing Neoadjuvant Oxaliplatin, Capecitabine, and Preoperative Radiotherapy With or Without Cetuximab Followed by Total Mesorectal Excision in Patients With High-Risk Rectal Cancer (EXPERT-C)
Alice Dewdney;David Cunningham;Josep Tabernero;Jaume Capdevila.
Journal of Clinical Oncology (2012)
High incidence of primary gastric lymphoma in northeastern Italy
C. Doglioni;A. Moschini;M. de Boni;A.C. Wotherspoon.
The Lancet (1992)
Variable frequencies of t(11;18)(q21;q21) in MALT lymphomas of different sites: significant association with CagA strains of H pylori in gastric MALT lymphoma
Hongtao Ye;Hongxiang Liu;Ayoma Attygalle;Andrew C. Wotherspoon.
Neoadjuvant capecitabine and oxaliplatin before chemoradiotherapy and total mesorectal excision in MRI-defined poor-risk rectal cancer: a phase 2 trial
Yu Jo Chua;Yu Jo Chua;Yolanda Barbachano;David Cunningham;Jacqui R Oates.
Lancet Oncology (2010)
Trisomy 3 in low-grade B-cell lymphomas of mucosa-associated lymphoid tissue.
Andrew C. Wotherspoon;Teresa M. Finn;Peter G. Isaacson.
EGILS consensus report. Gastric extranodal marginal zone B-cell lymphoma of MALT
A Ruskoné-Fourmestraux;W Fischbach;B M P Aleman;H Boot.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: